凯普生物
(300639)
| 流通市值：37.54亿 | | | 总市值：38.21亿 |
| 流通股本：6.35亿 | | | 总股本：6.47亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 685,932,480.14 | 712,357,379.26 | 905,902,260.49 | 709,501,229.43 |
| 应收票据及应收账款 | 1,019,731,312.68 | 1,098,622,081.75 | 1,375,456,417.28 | 1,746,789,347.07 |
| 其中：应收票据 | 6,734,842.92 | 4,251,369.7 | 3,553,079.41 | 3,289,529.97 |
| 应收账款 | 1,012,996,469.76 | 1,094,370,712.05 | 1,371,903,337.87 | 1,743,499,817.1 |
| 预付款项 | 4,798,064.84 | 5,256,120.47 | 12,207,779.21 | 10,148,942.76 |
| 其他应收款合计 | 13,463,896.44 | 10,981,484.87 | 16,613,124.77 | 16,504,003.96 |
| 其中:应收利息 | - | - | 6,884,412.04 | - |
| 存货 | 72,515,058.27 | 65,662,916.94 | 87,759,672.42 | 100,957,041.51 |
| 其他流动资产 | 367,873,642.69 | 332,135,121.76 | 96,567,213.58 | 96,626,348.88 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,164,935,866.8 | 2,225,642,938.29 | 2,494,553,729.99 | 2,840,582,138.51 |
| 非流动资产: | | | | |
| 长期股权投资 | 38,318,956.86 | 36,006,411.98 | 30,118,553.03 | 29,968,056.22 |
| 其他权益工具投资 | 292,205,481.55 | 292,230,568.69 | 300,647,509.55 | 300,655,749.89 |
| 其他非流动金融资产 | 217,470,038.72 | 217,470,038.72 | 214,000,000 | 214,000,000 |
| 固定资产 | 1,135,094,414.97 | 1,164,062,634.24 | 1,199,207,763.77 | 1,238,394,579.82 |
| 在建工程 | 235,854,212.92 | 232,586,931.57 | 194,237,568.07 | 195,117,087.18 |
| 使用权资产 | 9,427,884.97 | 10,882,687.53 | 16,853,859.56 | 20,624,012.26 |
| 无形资产 | 259,855,027.51 | 259,275,502.8 | 262,354,817.27 | 257,949,092.31 |
| 开发支出 | 27,434,848.55 | 23,849,054.52 | 21,457,417.48 | 22,641,018.37 |
| 长期待摊费用 | 31,933,196.68 | 37,047,986.54 | 39,365,483.14 | 44,059,954.36 |
| 递延所得税资产 | 86,299,021.03 | 86,321,250.52 | 263,890,029.93 | 204,914,275.19 |
| 其他非流动资产 | 35,629,408.7 | 37,609,295.31 | 56,943,130.79 | 54,103,280.2 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,369,522,492.46 | 2,397,342,362.42 | 2,599,076,132.59 | 2,582,427,105.8 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,534,458,359.26 | 4,622,985,300.71 | 5,093,629,862.58 | 5,423,009,244.31 |
| 流动负债: | | | | |
| 短期借款 | 21,747,112.03 | 21,627,740.3 | 21,402,910.55 | 500,388.89 |
| 应付票据及应付账款 | 89,667,067.37 | 106,745,565.53 | 95,164,481.88 | 126,147,404.16 |
| 应付账款 | 89,667,067.37 | 106,745,565.53 | 95,164,481.88 | 126,147,404.16 |
| 合同负债 | 15,208,593.14 | 14,859,766.41 | 13,841,442.86 | 9,863,910.6 |
| 应付职工薪酬 | 58,185,363.94 | 67,899,842.45 | 57,274,761.88 | 61,756,597.32 |
| 应交税费 | 15,100,473.56 | 13,189,791.93 | 20,933,709.47 | 16,896,125.15 |
| 其他应付款合计 | 208,209,140.02 | 208,308,817.9 | 164,772,103.68 | 164,052,538.81 |
| 应付股利 | - | 6,960,966.11 | 9,520,414.31 | 9,618,613.73 |
| 一年内到期的非流动负债 | 4,839,791.22 | 7,905,324.29 | 6,866,943.27 | 7,957,057.34 |
| 其他流动负债 | 4,280,469.83 | 1,009,578.01 | 668,372.42 | 777,666.87 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 417,238,011.11 | 441,546,426.82 | 380,924,726.01 | 387,951,689.14 |
| 非流动负债: | | | | |
| 长期借款 | 97,787,539.34 | 52,787,539.32 | 52,783,217.56 | 52,777,481.39 |
| 租赁负债 | 6,299,712.6 | 5,191,028.2 | 13,021,582.42 | 16,323,689.33 |
| 预计负债 | 603,112.29 | 692,998.57 | 46,895.62 | 46,895.62 |
| 递延收益 | 8,603,548.8 | 9,150,332.54 | 9,700,575.28 | 10,403,527.27 |
| 递延所得税负债 | 64,302,960.29 | 67,068,827.22 | 54,957,782.47 | 58,674,224.24 |
| 其他非流动负债 | - | - | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 177,596,873.32 | 134,890,725.85 | 130,510,053.35 | 138,225,817.85 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 594,834,884.43 | 576,437,152.67 | 511,434,779.36 | 526,177,506.99 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 646,500,674 | 646,500,674 | 646,500,674 | 646,500,674 |
| 资本公积 | 772,688,659.06 | 785,488,354.08 | 777,688,624.89 | 777,658,238.17 |
| 减:库存股 | 110,145,478.95 | 65,125,477.39 | 60,125,682.44 | 33,129,110.91 |
| 其他综合收益 | 188,499,506.63 | 191,845,343.3 | 180,691,322.41 | 196,975,182.52 |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 87,555,295.2 | 87,555,295.2 | 87,555,295.2 | 87,555,295.2 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | 2,435,877,716.45 | 2,463,181,689.27 | 2,856,140,551.33 | 3,041,134,437.43 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,020,976,372.39 | 4,109,445,878.46 | 4,488,450,785.39 | 4,716,694,716.41 |
| 少数股东权益 | -81,352,897.56 | -62,897,730.42 | 93,744,297.83 | 180,137,020.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,939,623,474.83 | 4,046,548,148.04 | 4,582,195,083.22 | 4,896,831,737.32 |
| 负债和股东权益合计 | 4,534,458,359.26 | 4,622,985,300.71 | 5,093,629,862.58 | 5,423,009,244.31 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |